After decades of nihilism, recent evidence indicates that
One way to achieve this goal is through physiological imaging, the aim being to obtain maps of the following four neurological outcome after acute stroke can be improved through three types of measures (Brott and Bogousslavsky, tissue subtypes: (i) already irreversibly damaged ('core');
(ii) at-risk (penumbra); (iii) mildly hypoperfused or simply 2000): (i) restoring perfusion in the ischaemic tissue with the thrombolytic agent recombinant tissue plasminogen autoregulated but normally not at-risk ('oligaemia'); and (iv) unaffected. To identify these tissue categories in an objective activator (rt-PA) given intravenously within 3 h of clinical onset; (ii) preventing secondary deleterious events such as manner, however, one needs first to determine thresholds that reliably and efficiently separate them (Fig. 1) . The threshold hyperglycaemia, pyrexia, hypoxia, systemic hypotension, stroke recurrence and pulmonary embolism, best achieved concept originates from classic experimental literature which clearly documented the existence of a penumbra threshold in specialized stroke units; and (iii) providing appropriate rehabilitation. The reperfusion strategy is based on for cerebral blood flow (CBF) at about 22 ml/100 g/min, while the infarction threshold depended on time elapsed since experimental evidence in the nonhuman primate with middle cerebral artery (MCA) occlusion that, surrounding the arterial occlusion but tended towards the penumbra threshold for times longer than 3 h (Lassen, 1990) . Hence, ever since profoundly ischaemic core of already irreversible damage, there exists an area of brain tissue (the 'penumbra') which, physiological imaging applications to clinical stroke emerged, investigators have attempted to determine such thresholds though severely ischaemic and functionally silent, can still escape infarction if perfusion is restored before a certain (see Heiss, 2000) . Recently, detailed PET studies in patients studied 5 to 18 h (mean 10 h) after onset reported a CBF time has elapsed (Lassen, 1990) ; the penumbra has been documented in man (Baron, 1999; Heiss, 2000) . Although penumbra threshold~17-22 ml/100 g/min, and an infarction threshold~7-8 ml/100 g/min and 0.87 mls/100 g/min for beneficial when considering cohorts, i.v. rt-PA is hazardous in individual patients owing to the several-fold increased CBF and oxygen consumption, respectively (with no clear threshold found for other haemodynamic variables) (Furlan risk of symptomatic haemorrhagic transformation (Brott and Bogousslavsky, 2000) . In addition, it is an expensive treatment et al., 1996; Marchal et al., 1996 Marchal et al., , 1999 . Problems with implementing this approach in the clinical realm are, however, which should only be used when necessary. Because of this, it would appear sensible to reserve rt-PA for those patients that (i) the CBF thresholds for infarction must depend on time elapsed, but the exact relationship is unknown in man; still having an area of critically ischaemic tissue at the time of assessment, i.e. excluding those with already completed (ii) the exact time of stroke onset can be difficult to ascertain in many patients; (iii) the CBF may be unreliable if studied irreversible damage due to rapid deterioration of the ischaemic tissue beyond reversibility or with already established alone if partial reperfusion has occurred; and (iv) although the oxygen consumption threshold is likely time-independent, spontaneous reperfusion (Baron et al., 1995) . Interestingly, one trial (in need of replication) found that in patients selected this variable is presently obtainable only with PET. Although more accessible methods such as SPECT, xenon-CT and for the presence of proximal MCA occlusion, the intraarterial administration of another thrombolytic agent, prodiffusion/perfusion MRI have been assessed for their ability to deliver clinically applicable penumbra and infarction urokinase, resulted in significant and large clinical benefits even if given as late as 6 h after stroke (Furlan et al., 1999) .
thresholds, much more work is necessary to validate them (Heiss, 2000) . There is thus the need to continue looking for This indicates that a proportion of the penumbra was still there long after the 3-h window in such patients, consistent more precise yet applicable ways to define these thresholds. In this issue of Brain, Heiss et al. (2001) for the first time with imaging studies (Marchal et al., 1996; Read et al., 2000) . Clearly, if i.v. thrombolysis is to be tested beyond the used the PET combination of 15 O-water, a perfusion tracer, and 11 C-labelled flumazenil (FMZ), a neuronal benzo-3-h time-point, the idea of selecting the appropriate patients becomes even more compelling. diazepine/GABA A receptor ligand known to be a potential marker of neuronal integrity (Sette et al., 1993) . Despite the referred to above and highlights the potential for application of SPECT radioligands. daunting complexities involved in delivering this in an emergent basis, they were able to study 10 patients within
© Oxford University Press 2001
Based on their calculations of the size of the tissue compartments, Heiss and colleagues go on to make 2-12 h of onset (mean 6 h). By means of late T 2 -weighted MRI, the acute-stage abnormalities in CBF and FMZ uptake pathophysiological interpretations that have far-reaching therapeutic implications, yet which could be contested (Heiss were mapped against the ultimate outcome of the tissue, i.e. infarction or integrity. Using a sophisticated statistical et al., 2001) . Firstly, they consider that because only~20% of the final infarct was penumbral at the time of assessment, approach based on histogram analysis, they then determined probabilistic penumbra and infarction thresholds for each one only that much would be salvageable by reperfusion. However, the penumbra is likely to be much larger earlier of these two parameters, and in turn, the tissue compartments referred to above. Specifically, the analysis disclosed that the on-which would explain the benefits from rt-PA within 3 h-and furthermore, the penumbra was as large as 55.9% penumbra threshold was best defined by CBF, and the infarction threshold by FMZ uptake. There are some individually with, in addition, the three larger fractions being observed in patients studied in the 6-11 h range (their Table  limitations in this study: (i) tissue outcome may have been altered by therapy in three rt-PA treated patients included; 1), similar to previous findings (Marchal et al., 1996) . Secondly, they consider that the small size of the (ii) only the cortical rim was assessable by FMZ, leaving the basal ganglia and white matter unexplored; (iii) the low subcompartment with both CBF above the penumbra threshold and FMZ above the infarction threshold that went unaffected-hemisphere cortical flow reported suggests that the CBF may have been underestimated, explaining the rather on to infarction (median 12.9%) may explain the failure of neuroprotection trials thus far. However, this compartment low penumbra CBF threshold obtained relative to previous reports; and (iv) the thresholds were derived from region-ofwas ജ45% in three patients (their Table 1 ), which would mean that proper case selection might reveal benefits even interest analysis, which may make them unsuitable for clinical application at the voxel level. Regardless, this study is for neuroprotection and, furthermore, it remains to be proven that only this subcompartment would be targeted by important in that it documents that not only CBF and oxygen consumption, but also a neuronal marker such as FMZ, can neuroprotection alone. The demise of the oligaemic compartment might also result from secondary events such be used to objectively map the tissue's status in acute stroke. Although only a proof-of-principle study since PET will not as hyperglycaemia, pyrexia, vasogenic oedema or systemic hypotension, which would explain the benefits from avoiding be clinically applicable in acute stroke in the foreseeable future, it paves the way for the other imaging methods such complications. In addition, this tissue was defined by a PROACT II study: a randomized controlled trial. JAMA 1999; 282:
CBF higher than the penumbra threshold, but, as said above, 2003-11. the latter was on the low side and its accuracy will need to be tested by replicating this study. Finally, it could be argued 
